Belite Bio, Inc (BLTE) stock
BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
$169.96+14.02 (+8.99%)
Close on Nov 12, 2026Market cap $6.69BP/E –Yield –
Belite Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Belite Bio's enterprise value was $5.78B on Nov 11, 2026, against $4.34B a year earlier. Over the last 5 years it ranged from $91.46M to $7.13B, with a median of $1.34B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.78B | +14.4% |
| 2025 | Dec 31, 2025 | $5.05B | +188.6% |
| 2024 | Dec 31, 2024 | $1.75B | +59.6% |
| 2023 | Dec 29, 2023 | $1.10B | +275.2% |
| 2022 | Dec 30, 2022 | $292.38M | – |
See a number that looks wrong?